Bill > HR113

This bill provides for research and education on triple-negative breast cancer, a particularly aggressive form of breast cancer that disproportionately affects minority women. It directs the National Institutes of Health to expand and coordinate research on triple-negative breast cancer, and requires the Centers for Disease Control and Prevention to develop and disseminate public information on the incidence, risk factors, and treatment options for this type of cancer. The bill also requires the Health Resources and Services Administration to provide information to healthcare providers on triple-negative breast cancer, including the elevated risk for minority women. The bill defines "minority women" as those belonging to a racial or ethnic minority group.